Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)

Overview

Provide pre-approval single patient Expanded Access (compassionate use) of abrocitinib for patients with severe uncontrolled atopic dermatitis

In Expanded Access, treating physicians are the Sponsor. Expanded Access requests from treating physicians may be submitted at www.pfizercares.com ; availability will depend on location/country.

Conditions

Interventions

Eligibility

Central Contacts